VACCINIA VIRUS - A TOOL FOR RESEARCH AND VACCINE DEVELOPMENT

被引：372
|
作者：
MOSS, B
机构：
[1] Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
来源：
SCIENCE | 1991年 / 252卷 / 5013期
关键词：
D O I：
10.1126/science.2047875
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Vaccinia virus is no longer needed for smallpox immunization, but now serves as a useful vector for expressing genes within the cytoplasm of eukaryotic cells. As a research tool, recombinant vaccinia viruses are used to synthesize biologically active proteins and analyze structure-function relations, determine the targets of humoral- and cell-mediated immunity, and investigate the immune responses needed for protection against specific infectious diseases. When more data on safety and efficacy are available, recombinant vaccinia and related poxviruses may be candidates for live vaccines and for cancer immunotherapy.
引用
收藏
页码：1662 / 1667
页数：6
相关论文
共 50 条
  • [31] ZIKA VIRUS: KNOWLEDGE GAPS AND VACCINE RESEARCH AND DEVELOPMENT CHALLENGES
    Jackson, Nicholas
    Lecouturier, Valerie
    Pugachev, Konstantin
    Burdin, Nicolas
    Kleanthous, Harry
    Kester, Kent
    Noriega, Fernando
    Tartaglia, Jim
    Heinrichs, Jon
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 44 - 44
  • [32] A review of vaccine research and development: The human immunodeficiency virus (HIV)
    Girard, Marc P.
    Osmanov, Saladin K.
    Kieny, Marie Paule
    [J]. VACCINE, 2006, 24 (19) : 4062 - 4081
  • [33] Human and bovine respiratory syncytial virus vaccine research and development
    Meyer, Gilles
    Deplanche, Martine
    Schelcher, Francois
    [J]. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2008, 31 (2-3) : 191 - 225
  • [34] IMMUNITY PRODUCED BY FORMALIN-KILLED VACCINIA VIRUS VACCINE
    BEUNDERS, BJ
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1964, 37 (02): : R4 - &
  • [35] A case of mistaken identity? Vaccinia virus in a live camelpox vaccine
    Yousif, A. A.
    Al-Ali, A. M.
    [J]. BIOLOGICALS, 2012, 40 (06) : 495 - 498
  • [36] Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus
    Huemer, Hartwig P.
    Lassnig, Caroline
    Bernhard, David
    Sturm, Sonja
    Nowotny, Norbert
    Kitchen, Maria
    Pavlic, Marion
    [J]. IMMUNOBIOLOGY, 2011, 216 (06) : 670 - 677
  • [37] Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing
    Somekh, E
    Smetana, Z
    Tanay, A
    Dalal, I
    Babai, I
    Mendelson, E
    [J]. VACCINE, 2004, 23 (03) : 321 - 324
  • [38] PROGRESS IN THE DEVELOPMENT OF A HEAT-STABLE RECOMBINANT RINDERPEST VACCINE USING AN ATTENUATED VACCINIA VIRUS VECTOR
    YAMANOUCHI, K
    BARRETT, T
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE DE L OFFICE INTERNATIONAL DES EPIZOOTIES, 1994, 13 (03): : 721 - 735
  • [39] Highly attenuated vaccinia virus DIs as a potential SARS vaccine
    Ishii, Koji
    Hasegawa, Hideki
    Nagata, Noriyo
    Mizutani, Tetsuya
    Morikawa, Shigeru
    Tashiro, Masato
    Suzuki, Tetsuro
    Taguchi, Fumihiro
    Takemori, Toshitada
    Miyamura, Tatsuo
    Tsunetsugu-Yokota, Yasuko
    [J]. NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES, 2006, 581 : 593 - 596
  • [40] Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
    Wyatt, LS
    Shors, ST
    Murphy, BR
    Moss, B
    [J]. VACCINE, 1996, 14 (15) : 1451 - 1458
12345